SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 469 filers reported holding SEAGEN INC in Q3 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,202,904 | +10.8% | 19,811 | +0.5% | 0.06% | +14.0% |
| Q2 2023 | $3,792,039 | +0.8% | 19,703 | +6.0% | 0.05% | -9.1% |
| Q1 2023 | $3,762,095 | +58.0% | 18,581 | +0.3% | 0.06% | +41.0% |
| Q4 2022 | $2,381,033 | +8.1% | 18,528 | +15.1% | 0.04% | -7.1% |
| Q3 2022 | $2,203,000 | -21.9% | 16,101 | +1.0% | 0.04% | -26.3% |
| Q2 2022 | $2,820,000 | +41.2% | 15,939 | +15.0% | 0.06% | +72.7% |
| Q1 2022 | $1,997,000 | -5.8% | 13,865 | +1.1% | 0.03% | 0.0% |
| Q4 2021 | $2,120,000 | -8.3% | 13,712 | +0.7% | 0.03% | -25.0% |
| Q3 2021 | $2,312,000 | +3.0% | 13,615 | -4.2% | 0.04% | +7.3% |
| Q2 2021 | $2,244,000 | +22.2% | 14,211 | +7.5% | 0.04% | +5.1% |
| Q1 2021 | $1,836,000 | -20.5% | 13,224 | +0.4% | 0.04% | -22.0% |
| Q4 2020 | $2,308,000 | – | 13,176 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |